SPOTLIGHT: AZ wants to sell Seroquel for bipolar use
AstraZeneca has asked the FDA to expand the use of its schizophrenia drug Seroquel to treatment of bipolar disorder. Report
Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product
Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.